Product Images Gabapentin

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 7 images provide visual information about the product associated with Gabapentin NDC 60760-741 by St. Mary's Medical Park Pharmacy, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

GABA - Gabapentin 60760 741 60

GABA - Gabapentin 60760 741 60

This is a description of a Gabapentin medication. It comes in capsule form and is 300mg. The package contains 60 capsules with NDC code 60760-741-60. The medication is manufactured by ScieGen Pharmaceuticals in Hauppauge, NY, and packaged by S, StMaws & Hllary’s in Oro Valley, AZ. The medication is to be stored at a controlled room temperature between 15°C to 30°C (59°F to 86°F).*

Figure 1 - image 01

Figure 1 - image 01

This is a chart of mean pain score over time comparing two groups: one on a fixed dose of Parkod and the other on a placebo or on 3600mg/day of Gabapentin. The pain score is measured on a scale of 0-4. The chart shows the baseline pain score and pain scores at subsequent weeks.*

Figure 2 - image 02

Figure 2 - image 02

This is a graph showing the mean pain score during a 4-week fixed dose period of Gabapentin (at two different doses) and a placebo among patients. The x-axis represents weeks, and the y-axis represents the mean pain score. There were 7 data points presented, including the baseline score, and the scores at the end of each week.*

Figure 3 - image 03

Figure 3 - image 03

Cockcroft and Gault Equation - image 04

Cockcroft and Gault Equation - image 04

Gabapentin Structural Formula - image 05

Gabapentin Structural Formula - image 05

Figure 4. Responder Rate in Patients Receiving gabapentin Expressed as a Difference from Placebo by Dose and Study: Adjunctive Therapy Studies in Patients ≥12 Years of Age with Partial Seizures - image 09

Figure 4. Responder Rate in Patients Receiving gabapentin Expressed as a Difference from Placebo by Dose and Study: Adjunctive Therapy Studies in Patients ≥12 Years of Age with Partial Seizures - image 09

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.